Barclays’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $30K | Hold |
|
|||||
2025
Q1 | $28K | Hold |
|
|||||
2024
Q4 | $32K | Sell |
|
|||||
2024
Q3 | $32K | Hold |
|
|||||
2024
Q2 | $34K | Hold |
|
|||||
2024
Q1 | $39K | Hold |
|
|||||
2023
Q4 | $30K | Sell |
|
|||||
2023
Q3 | $47K | Buy |
|
|||||
2023
Q2 | $47K | Sell |
|
|||||
2023
Q1 | $45K | Sell |
|
|||||
2022
Q4 | $478K | Buy |
|
|||||
2022
Q3 | $140K | Buy |
|
|||||
2022
Q2 | $90K | Sell |
|
|||||
2022
Q1 | $227K | Sell |
|
|||||
2021
Q4 | $783K | Buy |
|
|||||
2021
Q3 | $685K | Sell |
|
|||||
2021
Q2 | $488K | Buy |
|
|||||
2021
Q1 | $208K | Buy |
|
|||||
2020
Q4 | $16K | Hold |
|
|||||
2020
Q3 | $10K | Hold |
|
|||||
2020
Q2 | $13K | Hold |
|
|||||
2020
Q1 | $12K | Hold |
|
|||||
2019
Q4 | $20K | Sell |
|
|||||
2019
Q3 | $131K | Buy |
|
|||||
2019
Q2 | $148K | Hold |
|
|||||
2019
Q1 | $150K | Hold |
|
|||||
2018
Q4 | $124K | Hold |
|
|||||
2018
Q3 | $201K | Hold |
|
|||||
2018
Q2 | $306K | Hold |
|
|||||
2018
Q1 | $268K | Hold |
|
|||||
2017
Q4 | $371K | Hold |
|
|||||
2017
Q3 | $409K | Buy |
|
|||||
2017
Q2 | $233K | Hold |
|
|||||
2017
Q1 | $184K | Hold |
|
|||||
2016
Q4 | $183K | Hold |
|
|||||
2016
Q3 | $217K | Hold |
|
|||||
2016
Q2 | $250K | Hold |
|
|||||
2016
Q1 | $180K | Hold |
|
|||||
2015
Q4 | $239K | Buy |
|
|||||
2014
Q2 | – | Sell |
|
|||||
2014
Q1 | $121K | Buy |
|